Circle has called on EU policymakers to revise the MiCA framework for stablecoins, highlighting that only three of the world's top 30 stablecoins (USDC, USDG, EURC) currently comply. The company advocates preserving issuance arrangements involving European and overseas affiliates to avoid pushing users towards offshore providers. Circle also proposes replacing fixed bank deposit reserve requirements with liquidity-based rules and suggests a recognition process for foreign-regulated stablecoins, drawing on U.S. regulatory models. These changes aim to improve access to global stablecoins under EU supervision and support the growth of European-issued tokens like EURC, which recently surpassed €400 million in circulation.
Circle's call for MiCA changes comes as a backdrop to a mixed market performance among major cryptocurrencies on Pluang. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 02, 2026 02:41 WIB: out of 50 major cryptocurrencies, 30 rose and 19 fell. Notable movers include THETA with a price of Rp3.930 and a 1-day change of -3.06%, LTC at Rp1.214.867 up 2.71%, and UNI priced at Rp162.419 with a 1-day increase of 2.62%.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
